These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19404314

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The efficacy and tolerability of nebivolol in hypertensive African American patients.
    Saunders E, Smith WB, DeSalvo KB, Sullivan WA.
    J Clin Hypertens (Greenwich); 2007 Nov; 9(11):866-75. PubMed ID: 17978594
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly.
    Mazza A, Gil-Extremera B, Maldonato A, Toutouzas T, Pessina AC.
    Blood Press; 2002 Nov; 11(3):182-8. PubMed ID: 12126265
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.
    Deedwania P, Shea J, Chen W, Brener L.
    J Clin Hypertens (Greenwich); 2013 Apr; 15(4):270-8. PubMed ID: 23551727
    [Abstract] [Full Text] [Related]

  • 30. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
    Cazzola M, Matera MG, Ruggeri P, Sanduzzi A, Spicuzza L, Vatrella A, Girbino G.
    Respiration; 2004 Apr; 71(2):159-64. PubMed ID: 15031571
    [Abstract] [Full Text] [Related]

  • 31. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 32. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 33. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May 27; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 34. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 27; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 27; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 36. Comparative assessment of antihypertensive efficacy of DL-nebivolol and D-nebivolol in patients with confirmed mild to moderate hypertension.
    Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Cléroux J.
    J Cardiovasc Pharmacol; 1995 Apr 27; 25(4):619-24. PubMed ID: 7596131
    [Abstract] [Full Text] [Related]

  • 37. A dose-response trial of nebivolol in essential hypertension.
    Van Nueten L, Dupont AG, Vertommen C, Goyvaerts H, Robertson JI.
    J Hum Hypertens; 1997 Feb 27; 11(2):139-44. PubMed ID: 9140802
    [Abstract] [Full Text] [Related]

  • 38. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
    Lacourcière Y, Lefebvre J, Poirier L, Archambault F, Arnott W.
    Am J Hypertens; 1994 Feb 27; 7(2):137-45. PubMed ID: 8179848
    [Abstract] [Full Text] [Related]

  • 39. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group.
    Am J Hypertens; 2006 Dec 27; 19(12):1217-25. PubMed ID: 17161766
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H, Yang HM, Lee HY, Kim JJ, Choi DJ, Seung KB, Jeon ES, Ha JW, Rim SJ, Park JB, Shin JH, Oh BH.
    Clin Ther; 2012 Jun 27; 34(6):1273-89. PubMed ID: 22608107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.